Press Releases
NeurogesX to Pursue Expanded U.S Label for Qutenza(R) 8% Patch in HIV-Associated Neuropathy
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced plans to pursue a U.S. label expansion for Qutenza(R) (capsaicin) 8% patch to include patients with painful HIV-associated neuropathy (HIV-AN, also referred to...
Press Releases
Italvacuum to Attend India CHEM 2010
We are pleased to announce that Italvacuum is participating India CHEM 2010, the largest event of the chemical and petrochemical industry in India. The 6th edition of this international conference and exhibition will take place in...
Press Releases
AVEVA to Exhibit at Drug Delivery Partnerships 2011
Aveva Drug Delivery Systems is pleased to announce that it will exhibit at Drug Delivery Partnerships on 26-28 January 2011 in Miami, Florida, US. Aveva Drug Delivery Systms is part of the Nitto Denko Group of ...
Press Releases
APR and Labtec enter into exclusive License Agreement with Ferrer International
APR and its development partner Labtec have entered into an exclusive licensing agreement with the leading European pharmaceutical company Ferrer Internacional (Ferrer) for the promotion, distribution and marketing of Donepezil Oral Dispersible Film (ODF) in Spain, Portugal and Germany....
Press Releases
Genzyme’s Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from Phase 2 Trial
Genzyme Corporation reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial. This sub-group analysis found that nearly 90 percent of alemtuzumab-treated patients were free of sustained accumulation of disability, and that patients receiving alemtuzumab also...
Press Releases
Weight Watchers and Merck Collaborate to Help Physicians Fight Obesity Through Lifestyle Management Approach
NEW YORK, NY and Whitehouse Station, NJ (October 13, 2010) – Weight Watchers International, Inc., the world's leading provider of weight management services, and Merck, a global healthcare leader, announced today an innovative collaboration focused on fighting obesity. The...
Press Releases
Pfizer to Acquire King Pharmaceuticals, Inc.
Pfizer Inc.and King Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement. Under the terms of the agreement, Pfizer will acquire King, a diversified specialty pharmaceutical discovery and clinical development company, for $3.6 billion in cash,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
